HIGH

Apotex Recalls Ophthalmic Solution Over Sterility Concerns

Apotex Inc. recalled 151,034 bottles of Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution on September 5, 2025. The recall stems from a lack of assurance of sterility due to improper bottle sealing. Consumers should stop using the product immediately and contact their healthcare provider or Apotex Corp.

Quick Facts at a Glance

Recall Date
September 5, 2025
Hazard Level
HIGH
Brands
BRIMONIDINE TARTRATE/TIMOLOL MALEATE OPHTHALMIC SOLUTION, Apotex Corp.
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL

Hazard Information

Lack of Assurance of Sterility; atypical weight loss due to improper bottle sealing leading to potential sterility concerns

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact Apotex Corp. or your healthcare provider for guidance. Notification method: Letter

Product Details

The recalled products include 5 mL and 10 mL bottles of Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution. The NDC for the 5 mL bottle is 60505-0589-1 and for the 10 mL bottle, it is 60505-0589-2. These products were distributed nationwide in the United States.

The Hazard

The recall was initiated due to a lack of assurance of sterility resulting from atypical weight loss caused by improper bottle sealing. This defect raises concerns about the product's safety and efficacy.

Reported Incidents

As of now, there have been no reported incidents or injuries associated with the use of the recalled ophthalmic solution. However, the potential risk to consumers remains high.

What to Do

Consumers and healthcare providers should stop using the product immediately. Contact Apotex Corp. or your healthcare provider for further guidance.

Contact Information

For more information, consumers can visit the FDA recall notice at https://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?recall_number=D-0676-2025 or call Apotex Corp.

Key Facts

  • Recall date: September 5, 2025
  • Quantity: 151,034 bottles
  • NDC 60505-0589-1 (5 mL), NDC 60505-0589-2 (10 mL)
  • Health Hazard: High
  • Manufactured by Apotex Inc., Ontario, Canada

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Classification

Product Details

Model Numbers
a) lot # VE0614 exp. date 12/2025 UPC:(01)00360505058914 (5 mL) b) lot # VE0616 exp. date 12/2025 UPC:(01)0(03)60505058921 (10 mL)
UPC Codes
60505-0589
60505-0589-1
60505-0589-2
+3 more
Affected States
ALL
Report Date
October 8, 2025
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls

HIGH

Acuity Specialty Products Recalls Hand Sanitizer Due to Methanol Risk

Acuity Specialty Products recalled its Wyandotte Sanifect E3 hand sanitizer on September 29, 2025. The recall affects multiple package configurations due to potential methanol contamination. Consumers should stop using the product immediately and contact the company for guidance.

Acuity Specialty Products
cGMP deviations:
Read more
HIGH

AFCO Hand Sanitizer Recalled Due to Methanol Risk

AFCO recalled hand sanitizer on September 29, 2025, due to a risk of methanol contamination. The company failed to conduct required testing on incoming alcohol components. Consumers should stop using the product immediately.

AFCO
cGMP deviations:
Read more